← All tickers

Is CAPR Worth Buying in 2026?

Capricor Therapeutics Inc

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Capricor Therapeutics Inc (CAPR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: strong 1-year return of +204.0%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-9.11% over 10 days); RSI 29 — oversold; 3-month momentum negative (-44.1%). Currently 51.2% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

CAPR is trading below its 200-day MA ($23.33) — a key warning sign the longer-term trend is under pressure. An RSI of 29.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +204.0% compares to +16.5% for SPY (beat the market by 187.5%). The current 51.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $30,401 today
vs. S&P 500 (SPY) — same period beat market by 187.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($23.33)
✗Above 50-day MA ($25.46)
!RSI(14) neutral zone (30–70) — currently 29.4
✓Positive return (+204.0%)
!Within 10% of period high (−51.2%)
Period Range $19.70
$4.30 $40.37
RSI (14) 29.4
0 · OversoldOverbought · 100

Key Metrics

Price$19.70
Period Return+204.0%
Period High$40.37
Period Low$4.30
Drawdown−51.2%
MA-50$25.46
MA-200$23.33
RSI (14)29.4
Avg Volume (30d)1.7M
vs. SPYbeat by 187.5%
Return Rank#51 of 999

Trade CAPR

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers